<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Cheminform</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Cheminform</journal-id>
    <journal-title-group>
      <journal-title>Journal of Cheminformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-2946</issn>
    <publisher>
      <publisher-name>Springer International Publishing</publisher-name>
      <publisher-loc>Cham</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8740492</article-id>
    <article-id pub-id-type="publisher-id">580</article-id>
    <article-id pub-id-type="doi">10.1186/s13321-021-00580-6</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HobPre: accurate prediction of human oral bioavailability for small molecules</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wei</surname>
          <given-names>Min</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Xudong</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pan</surname>
          <given-names>Xiaolin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Bo</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ji</surname>
          <given-names>Changge</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2853-7910</contrib-id>
        <name>
          <surname>Qi</surname>
          <given-names>Yifei</given-names>
        </name>
        <address>
          <email>yfqi@fudan.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Zhang</surname>
          <given-names>John Z. H.</given-names>
        </name>
        <address>
          <email>John.zhang@nyu.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.22069.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 6365</institution-id><institution>Shanghai Engineering Research Center of Molecular Therapeutics &amp; New Drug Development, Shanghai Key Laboratory of Green Chemistry &amp; Chemical Process, School of Chemistry and Molecular Engineering, </institution><institution>East China Normal University, </institution></institution-wrap>Shanghai, 200062 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.449457.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 5376 0118</institution-id><institution>NYU-ECNU Center for Computational Chemistry at NYU Shanghai, </institution></institution-wrap>Shanghai, 200062 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>Department of Medicinal Chemistry, School of Pharmacy, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, 201203 China </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>Department of Chemistry, </institution><institution>New York University, </institution></institution-wrap>New York, NY 10003 USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shenzhen, Guangdong China </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.163032.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id><institution>Collaborative Innovation Center of Extreme Optics, </institution><institution>Shanxi University, </institution></institution-wrap>Taiyuan, Shanxi 030006 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>6</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>6</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>14</volume>
    <elocation-id>1</elocation-id>
    <history>
      <date date-type="received">
        <day>26</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>28</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <title>Graphical Abstract</title>
      <p id="Par1">Human oral bioavailability (HOB) is a key factor in determining the fate of new drugs in clinical trials. HOB is conventionally measured using expensive and time-consuming experimental tests. The use of computational models to evaluate HOB before the synthesis of new drugs will be beneficial to the drug development process. In this study, a total of 1588 drug molecules with HOB data were collected from the literature for the development of a classifying model that uses the consensus predictions of five random forest models. The consensus model shows excellent prediction accuracies on two independent test sets with two cutoffs of 20% and 50% for classification of molecules. The analysis of the importance of the input variables allowed the identification of the main molecular descriptors that affect the HOB class value. The model is available as a web server at <ext-link ext-link-type="uri" xlink:href="http://www.icdrug.com/ICDrug/ADMET">www.icdrug.com/ICDrug/ADMET</ext-link> for quick assessment of oral bioavailability for small molecules. The results from this study provide an accurate and easy-to-use tool for screening of drug candidates based on HOB, which may be used to reduce the risk of failure in late stage of drug development.</p>
      <p id="Par100">
        <graphic position="anchor" xlink:href="13321_2021_580_Figa_HTML" id="MO11"/>
      </p>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13321-021-00580-6.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Classification</kwd>
      <kwd>Oral bioavailability</kwd>
      <kwd>ADMET</kwd>
      <kwd>Molecular descriptors</kwd>
      <kwd>Prediction</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Key R&amp;D Program of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2016YFA0501700</award-id>
        <principal-award-recipient>
          <name>
            <surname>Qi</surname>
            <given-names>Yifei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>22033001</award-id>
        <award-id>21933010</award-id>
        <principal-award-recipient>
          <name>
            <surname>Qi</surname>
            <given-names>Yifei</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>John Z. H.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007219</institution-id>
            <institution>natural science foundation of shanghai</institution>
          </institution-wrap>
        </funding-source>
        <award-id>19ZR1473600</award-id>
        <principal-award-recipient>
          <name>
            <surname>Qi</surname>
            <given-names>Yifei</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>Â© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par20">Poor pharmacokinetic properties, including absorption, distribution, metabolism, excretion, and toxicity (ADMET), are the key reasons of late-stage failures in drug development [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, ADMET assessments of candidate compounds during the early stages of drug discovery have become critical for improving the success rate of drug discovery and reducing the risk of late-stage attrition [<xref ref-type="bibr" rid="CR2">2</xref>]. However, experimental testing of ADMET properties is time-consuming and costly. Thus, the accurate prediction of these properties is becoming increasingly important in drug discovery.</p>
    <p id="Par21">Among the ADMET properties, one of the most important pharmacokinetic characteristics of newly developed drugs is high oral bioavailability. Because oral administration is convenient and does not damage the skin or mucous membranes, 80% of the worldâs drugs are administered orally [<xref ref-type="bibr" rid="CR3">3</xref>]. Human oral bioavailability (HOB) is an important pharmacokinetic parameter that measures the amount of a drug that actually enters circulation within the body after ingestion. If intravenous administration is used, the human body can use the blood to deliver the drug to the site where it can exert pharmacological effects through the systemic circulation. Higher oral availability of the drug can reduce the amount of administration required to achieve the expected pharmacological effect because it can reduce the side effects and toxicity risks brought by the drug. On the other hand, poor oral bioavailability can lead to inefficiency of drugs and high inter-individual variability in the use of drugs, triggering some unpredictable drug reactions in the human body. In the actual drug development process, approximately 50% of candidate drugs fail due to low oral availability [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, the level of oral availability is one of the key factors determining the success or failure of clinical trials of new drugs.</p>
    <p id="Par22">Experimental measurements of drug HOB are not only expensive, but also particularly time-consuming. Therefore, the development of a predictive model that can evaluate the HOB of a candidate compound before synthesis is of great help to drug discovery. Because the oral availability of a drug is affected by various biological, physical and chemical factors, such as the solubility of chemicals in the gastrointestinal tract, the permeability of the intestinal membrane, and the first pass metabolism of the intestine and liver, it is a very difficult and challenging task to develop accurate models to predict HOB. Nonetheless, a number of prediction models based on quantitative structure property relationships (QSPR) have been published [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. For example, FalcÃ³n-Cano et al. used 1448 molecules and obtained a consensus model with an accuracy of 78% [<xref ref-type="bibr" rid="CR8">8</xref>]. Yang et al. used the random forest algorithm and 995 molecules to develop the admetSAR method with an accuracy of 69.7% [<xref ref-type="bibr" rid="CR9">9</xref>]. On the basis of 995 data points, Kim et al. obtained 76% accuracy using the logistic classifier method [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
    <p id="Par23">In this study, we collected an HOB dataset composed of 1588 molecules and proposed a new model for HOB prediction based on machine learning. Using random forest (RF) [<xref ref-type="bibr" rid="CR11">11</xref>â<xref ref-type="bibr" rid="CR13">13</xref>] and two cutoffs of 20% and 50% for classifying molecules, we developed consensus models with a state-of-the-art accuracy on two independent test sets. Moreover, the importance of input molecular features to the prediction results was analyzed using the SHapley Additive exPlanation (SHAP) algorithm [<xref ref-type="bibr" rid="CR14">14</xref>], revealing key molecular properties that affect HOB.</p>
  </sec>
  <sec id="Sec2">
    <title>Materials and methods</title>
    <sec id="Sec3">
      <title>Classification of positive and negative data</title>
      <p id="Par24">The performance of a classifier strongly depends on how the positive and negative samples are defined. However, there is still no consensus criterion to define positive and negative samples in HOB prediction. In previous studies, four cutoff values have been used: 20% (if HOBââ¥â20%, then the molecule belongs to the positive class; otherwise, it is a negative example) [<xref ref-type="bibr" rid="CR15">15</xref>], 30% [<xref ref-type="bibr" rid="CR16">16</xref>], 50% [<xref ref-type="bibr" rid="CR17">17</xref>], and 80% [<xref ref-type="bibr" rid="CR5">5</xref>] (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). We have therefor used two cutoffs 50% and 20% for labeling molecules in this study, which are used in more recent methods.</p>
    </sec>
    <sec id="Sec4">
      <title>Dataset preparation</title>
      <p id="Par25">The HOB training and test datasets from FalcÃ³n-Cano et al. [<xref ref-type="bibr" rid="CR8">8</xref>] were used in this study, which includes 1157 training and 290 test molecules. The 290 test molecules (test set 1) were selected by randomly selecting 20% of all molecules. Three molecules in the test set 1 had wrong values and were manually corrected according to the relevant literatures [<xref ref-type="bibr" rid="CR18">18</xref>â<xref ref-type="bibr" rid="CR21">21</xref>]. An additional test set of 27 molecules was collected from a number of publications [<xref ref-type="bibr" rid="CR8">8</xref>] and was then combined with the HOB data from ChEMBL to form an additional test set of 141 molecules (Test set 2, Table <xref rid="Tab1" ref-type="table">1</xref>). To ensure that molecules in test set 2 do not overlap with the molecules in training set and test set 1, 2D structures were first generated and used to remove duplicates followed by deduplication using molecular fingerprints. Neither test set 1 nor test set 2 was used during the training.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Information of the training and test datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cutoff</th><th align="left">Data sets</th><th align="left">Molecules</th><th align="left">Positive</th><th align="left">Negative</th></tr></thead><tbody><tr><td align="left" rowspan="3">Fâ=â50%</td><td align="left">Training set</td><td align="left">1157</td><td align="left">536</td><td align="left">621</td></tr><tr><td align="left">Test set 1</td><td align="left">290</td><td align="left">169</td><td align="left">121</td></tr><tr><td align="left">Test set 2</td><td align="left">141</td><td align="left">90</td><td align="left">51</td></tr><tr><td align="left" rowspan="3">Fâ=â20%</td><td align="left">Training set</td><td align="left">1142</td><td align="left">859</td><td align="left">283</td></tr><tr><td align="left">Test set 1</td><td align="left">287</td><td align="left">214</td><td align="left">73</td></tr><tr><td align="left">Test set 2</td><td align="left">133</td><td align="left">128</td><td align="left">5</td></tr></tbody></table></table-wrap></p>
      <p id="Par26">The labeling of molecules using the 50% cutoff was obtained directly from FalcÃ³n-Cano et al. For the 20% cutoff, some molecules cannot be classified due to inaccurate experimental values. These molecules were discarded, leaving training set with 1142 molecules, test set 1 with 287 molecules and test set 2 with 133 molecules (Table <xref rid="Tab1" ref-type="table">1</xref>).</p>
      <p id="Par27">All molecules in the training and test sets were converted to 3D structures using the RDKit package. However, the calculated 3D fingerprints and descriptors were not used during model training due to null value or small variance for many of the molecules.</p>
      <p id="Par28">To evaluate the similarity between the training set and the test sets, we calculated the max Tanimoto coefficient similarity of each molecule in the test sets with all molecules in the training set. The similarity ranges from 0.1 to 1 in test set 1 and 0.2 to 1 in test set 2 (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). The average similarity between the test set 1 and the training set is 0.655, and the average similarity between the test set 2 and the training set is 0.612.<fig id="Fig1"><label>Fig. 1</label><caption><p>Maximum similarity of each molecule in the test sets to the molecules in the training set. The similarity was calculated using the Tanimoto coefficient similarity on the topological fingerprints of the molecules</p></caption><graphic xlink:href="13321_2021_580_Fig1_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>Calculation of descriptors</title>
      <p id="Par29">We used Mordred [<xref ref-type="bibr" rid="CR22">22</xref>] software to calculate 1614 molecular descriptors and fingerprints (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2). Descriptors that had zero values or zero variance for all compounds were removed, reducing the total number of descriptors to 1143. All these 1143 features were used for training RF models.</p>
    </sec>
    <sec id="Sec6">
      <title>Evaluation of models</title>
      <p id="Par30">The performance of the individual and consensus models was evaluated by analyzing the sensitivity (SE), specificity (SP), accuracy of prediction (ACC), Matthewâs correlation coefficient (MCC) [<xref ref-type="bibr" rid="CR23">23</xref>] and F1_score.<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ACC=\frac{TP+TN}{TP+FP+TN+FN}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2021_580_Article_Equa.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SE =\frac{TP}{TP+FN}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2021_580_Article_Equb.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$SP=\frac{TN}{TN+FP}$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TN</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2021_580_Article_Equc.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equd"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$MCC=\frac{TP\times TN-FN\times FP}{\sqrt{(TP+FN)(TP+FN)(TN+FN)(TN+FP)}}$$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mrow><mml:mi>M</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>Ã</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo>Ã</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:msqrt><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msqrt></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2021_580_Article_Equd.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Eque"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$F{1}_{score}=2\times \frac{precision\times recall}{precision+recall}$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">score</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>Ã</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>Ã</mml:mo><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2021_580_Article_Eque.gif" position="anchor"/></alternatives></disp-formula>
where TP denotes true positive, FP is false positive, FN is false negative, and TN is true negative. In addition, the receiver operating characteristic (ROC) curve and the area under the curve (AUC) were also calculated.</p>
      <p id="Par32">We utilized the SHapley Additive exPlanation (SHAP) algorithm to explain the prediction model by providing consistent and locally accurate attribution values (SHAP values) for each feature within each prediction model [<xref ref-type="bibr" rid="CR24">24</xref>]. The SHAP values evaluate the importance of the output resulting from the inclusion of a certain feature A for all combinations of features other than A.</p>
    </sec>
  </sec>
  <sec id="Sec7">
    <title>Results</title>
    <sec id="Sec8">
      <title>Performance of the models and comparison with previous methods</title>
      <p id="Par33">For the 50% cutoff, we first assembled a training set of 1157 molecules and two independent test sets with 290 and 146 molecules from the literature and public databases (see <xref rid="Sec2" ref-type="sec">Materials and methods</xref>). The input features of the models include 1143 2D descriptors calculated with the Mordred package (see <xref rid="Sec2" ref-type="sec">Materials and methods</xref> for details). Five individual RF models were first trained on the training set with fivefold cross-validation, using grid search and accuracy score (ACC) for hyperparameter optimization to obtain the best n_estimators and min_samples_leaf values while leaving the remaining hyperparameters set to default values (Table <xref rid="Tab2" ref-type="table">2</xref>). Restricting the number of tunable hyper-parameters may reduce the risk of overfitting. The accuracy of the our model is 0.86â0.90 on the training set (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S3, S4), and 0.74â0.77 on test set 1 (Table <xref rid="Tab3" ref-type="table">3</xref>). The moderate decrease of accuracy on the test set suggests that our model has certain extend of overfitting but not severe. We then combined the five RF models to obtain a voting model. The final bioavailability class is the result of voting from each classification model with equal weight. Individual models can usually identify different aspects of the relationship between independent variables and dependent variables, and the relationships between the variables identified by those models may be different. In certain cases, the usage of a consensus model can greatly reduce the prediction error [<xref ref-type="bibr" rid="CR25">25</xref>â<xref ref-type="bibr" rid="CR27">27</xref>]. The accuracy of the five individual models ranges from 0.742 to 0.808 on the two test sets (Table <xref rid="Tab3" ref-type="table">3</xref>). The consensus model shows improvement in accuracy on test set 1 and test set 2. The AUC values of the consensus model were 0.830 and 0.878 on the two test sets (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>). In addition, we merged the training set and test set 1, and used the same protocol to train five random forest models and obtained a consensus model from fivefold cross-validation. This whole process was repeated 50 times, and the average accuracy on test 2 was 0.826 with a standard deviation of 0.014, which was close to the accuracy of 0.823 when test set 1 is not included for training.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Optimized parameters of the RF models from fivefold cross-validation on the training set when the cutoff is 50%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameters</th><th align="left">Parameters meaning</th><th align="left">Optimal value</th></tr></thead><tbody><tr><td align="left">n_estimators</td><td align="left">The number of trees in the forest</td><td align="left">31</td></tr><tr><td align="left">min_samples_leaf</td><td align="left">The minimum number of samples required to be at a leaf node</td><td align="left">6</td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Performance of the RF models on the two test sets when the cutoff is 50%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Data set</th><th align="left">Model</th><th align="left">SE</th><th align="left">SP</th><th align="left">ACC</th><th align="left">AUC</th><th align="left">MCC</th><th align="left">F1-score</th></tr></thead><tbody><tr><td align="left" rowspan="6">Test set 1</td><td align="left">Model 1</td><td char="." align="char">0.779</td><td char="." align="char">0.732</td><td char="." align="char">0.752</td><td char="." align="char">0.819</td><td char="." align="char">0.505</td><td char="." align="char">0.774</td></tr><tr><td align="left">Model 2</td><td char="." align="char">0.746</td><td char="." align="char">0.786</td><td char="." align="char">0.769</td><td char="." align="char">0.826</td><td char="." align="char">0.529</td><td char="." align="char">0.798</td></tr><tr><td align="left">Model 3</td><td char="." align="char">0.713</td><td char="." align="char">0.750</td><td char="." align="char">0.734</td><td char="." align="char">0.790</td><td char="." align="char">0.460</td><td char="." align="char">0.766</td></tr><tr><td align="left">Model 4</td><td char="." align="char">0.745</td><td char="." align="char">0.732</td><td char="." align="char">0.738</td><td char="." align="char">0.801</td><td char="." align="char">0.473</td><td char="." align="char">0.764</td></tr><tr><td align="left">Model 5</td><td char="." align="char">0.713</td><td char="." align="char">0.768</td><td char="." align="char">0.745</td><td char="." align="char">0.813</td><td char="." align="char">0.479</td><td char="." align="char">0.777</td></tr><tr><td align="left">Consensus model</td><td char="." align="char"><bold>0.787</bold></td><td char="." align="char"><bold>0.797</bold></td><td char="." align="char"><bold>0.793</bold></td><td char="." align="char"><bold>0.830</bold></td><td char="." align="char"><bold>0.580</bold></td><td char="." align="char"><bold>0.817</bold></td></tr><tr><td align="left">Test set 2</td><td align="left">Model 1</td><td char="." align="char">0.673</td><td char="." align="char">0<bold>.899</bold></td><td char="." align="char">0.816</td><td char="." align="char">0.839</td><td char="." align="char">0.596</td><td char="." align="char">0.860</td></tr><tr><td align="left"/><td align="left">Model 2</td><td char="." align="char">0.673</td><td char="." align="char">0.876</td><td char="." align="char">0.801</td><td char="." align="char"><bold>0.880</bold></td><td char="." align="char">0.565</td><td char="." align="char">0.848</td></tr><tr><td align="left"/><td align="left">Model 3</td><td char="." align="char">0.577</td><td char="." align="char">0.854</td><td char="." align="char">0.752</td><td char="." align="char">0.840</td><td char="." align="char">0.452</td><td char="." align="char">0.813</td></tr><tr><td align="left"/><td align="left">Model 4</td><td char="." align="char"><bold>0.692</bold></td><td char="." align="char">0.865</td><td char="." align="char">0.801</td><td char="." align="char">0.857</td><td char="." align="char">0.568</td><td char="." align="char">0.846</td></tr><tr><td align="left"/><td align="left">Model 5</td><td char="." align="char">0.673</td><td char="." align="char">0.831</td><td char="." align="char">0.773</td><td char="." align="char">0.862</td><td char="." align="char">0.509</td><td char="." align="char">0.822</td></tr><tr><td align="left"/><td align="left">Consensus model</td><td char="." align="char"><bold>0.692</bold></td><td char="." align="char"><bold>0.899</bold></td><td char="." align="char"><bold>0.823</bold></td><td char="." align="char">0.872</td><td char="." align="char"><bold>0.612</bold></td><td char="." align="char"><bold>0.865</bold></td></tr></tbody></table><table-wrap-foot><p>Bold numbers refer to the maximum value (optimum value) obtained from the corresponding evaluation index</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>The AUCs of RF models on the two test sets when the cutoff is 50%</p></caption><graphic xlink:href="13321_2021_580_Fig2_HTML" id="MO3"/></fig></p>
      <p id="Par34">To further estimate the accuracy of the models, the accuracy of our model on test set 1 was compared with those of previously published HOB models (Table <xref rid="Tab4" ref-type="table">4</xref>). It should be noted that we used the same training and test sets as FalcÃ³n-Cano et al., but the accuracies of other models are directly taken from the respective literature publications, which may use different data sets.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison with other prediction models on test set 1 when the cutoff is 50%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Data set size</th><th align="left">Method</th><th align="left">ACC (test)</th><th align="left">AUC (test)</th><th align="left">Cut-off value</th></tr></thead><tbody><tr><td align="left">Current study</td><td align="left">1588</td><td align="left">RF</td><td char="." align="char">0.793</td><td align="left">0.830</td><td align="left">Fâ=â50%</td></tr><tr><td align="left">FalcÃ³n-Cano et al. [<xref ref-type="bibr" rid="CR8">8</xref>]</td><td align="left">1448</td><td align="left">CART, MLP, NB, GBT, SVM</td><td char="." align="char">0.783<sup>a</sup></td><td align="left">0.800<sup>a</sup></td><td align="left">Fâ=â50%</td></tr><tr><td align="left">admetSAR [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td align="left">995</td><td align="left">RF</td><td char="." align="char">0.697<sup>a</sup></td><td align="left">0.752<sup>a</sup></td><td align="left"><p>logK(%F)<sup>b</sup>â=â0</p><p>(Fâ=â50%)</p></td></tr><tr><td align="left">Kim et al. [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">995</td><td align="left">RF, SVM-consensus CTG</td><td char="." align="char">0.76<sup>a</sup></td><td align="left">NA</td><td align="left">Fâ=â50%</td></tr></tbody></table><table-wrap-foot><p><italic>CART</italic> classification and regression trees; <italic>MLP</italic> multilayer perceptron; <italic>NB</italic> naive Bayes; <italic>GBT</italic> gradient boosted trees; <italic>SVM</italic> support vector machines</p><p><sup>a</sup>Taken from respective references</p><p><sup>b</sup><inline-formula id="IEq1"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{log}K\left(\mathrm{\%}F\right)=\mathrm{log}\left(\frac{\mathrm{\%}F}{100-\mathrm{\%}F}\right)$$\end{document}</tex-math><mml:math id="M12"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mi>K</mml:mi><mml:mfenced close=")" open="("><mml:mo>%</mml:mo><mml:mi>F</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="normal">log</mml:mi><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mo>%</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mn>100</mml:mn><mml:mo>-</mml:mo><mml:mo>%</mml:mo><mml:mi>F</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_580_Article_IEq1.gif"/></alternatives></inline-formula></p></table-wrap-foot></table-wrap></p>
      <p id="Par35">Among these reported models, only admetSAR and ADMETlab provide an online prediction server that enables a direct comparison with our method based on the same test data. However, ADMETlab used different cutoffs of 30% and 20%. Therefore, we compared our method with admetSAR, which also uses Fâ=â50% as the cut-off value. For a fair comparison, the molecules in the admetSAR training set were removed from the two test sets. Our model is more accurate than admetSAR in terms of SP, ACC and AUC (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Comparison with admetSAR on test sets 1 and 2 when the cutoff is 50%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Data set</th><th align="left">Model</th><th align="left">SE</th><th align="left">SP</th><th align="left">ACC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="2">Test set 1<sup>a</sup></td><td align="left">Current Study</td><td char="." align="char"><bold>0.824</bold></td><td char="." align="char"><bold>0.819</bold></td><td char="." align="char"><bold>0.821</bold></td><td char="." align="char"><bold>0.862</bold></td></tr><tr><td align="left">admetSAR</td><td char="." align="char">0.784</td><td char="." align="char">0.777</td><td char="." align="char">0.780</td><td char="." align="char">0.831</td></tr><tr><td align="left" rowspan="2">Test set 2<sup>a</sup></td><td align="left">Current Study</td><td char="." align="char">0.692</td><td char="." align="char"><bold>0.825</bold></td><td char="." align="char"><bold>0.773</bold></td><td char="." align="char"><bold>0.849</bold></td></tr><tr><td align="left">admetSAR</td><td char="." align="char"><bold>0.769</bold></td><td char="." align="char">0.725</td><td char="." align="char">0.742</td><td char="." align="char">0.787</td></tr></tbody></table><table-wrap-foot><p>Bold numbers refer to the maximum value (optimum value) obtained from the corresponding evaluation index</p><p><sup>a</sup>Test set 1 and 2 contain 168 and 66 molecules after removing the molecules used in the admetSAR training set</p></table-wrap-foot></table-wrap></p>
      <p id="Par36">For the Fâ=â20% cutoff, we used the same method to build a consensus model (Table <xref rid="Tab6" ref-type="table">6</xref>). The accuracy of the five individual models ranges from 0.739 to 0.932 on the two test sets (Table <xref rid="Tab7" ref-type="table">7</xref>). The consensus model shows improvement in accuracy on test set 1 and test set 2. The AUC values of the consensus model were 0.804 and 0.978 on the two test sets.<table-wrap id="Tab6"><label>Table 6</label><caption><p>Optimized parameters of the RF models from fivefold cross-validation on the training set when the cutoff is 20%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameters</th><th align="left">Parameters meaning</th><th align="left">Optimal value</th></tr></thead><tbody><tr><td align="left">n_estimators</td><td align="left">The number of trees in the forest</td><td align="left">10</td></tr><tr><td align="left">min_samples_leaf</td><td align="left">The minimum number of samples required to be at a leaf node</td><td align="left">6</td></tr></tbody></table></table-wrap><table-wrap id="Tab7"><label>Table 7</label><caption><p>Performance of the RF models on the two test sets when the cutoff is 20%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Data set</th><th align="left">Model</th><th align="left">SE</th><th align="left">SP</th><th align="left">ACC</th><th align="left">AUC</th><th align="left">MCC</th><th align="left">F1-score</th></tr></thead><tbody><tr><td align="left" rowspan="6"><p>Test set 1</p><p>(287)</p></td><td align="left">Model 1</td><td align="left">0.370</td><td char="." align="char">0.869</td><td char="." align="char">0.742</td><td char="." align="char">0.736</td><td char="." align="char">0.264</td><td char="." align="char">0.824</td></tr><tr><td align="left">Model 2</td><td align="left">0.479</td><td char="." align="char">0.864</td><td char="." align="char">0.767</td><td char="." align="char">0.767</td><td char="." align="char">0.360</td><td char="." align="char">0.847</td></tr><tr><td align="left">Model 3</td><td align="left">0.452</td><td char="." align="char">0.893</td><td char="." align="char">0.780</td><td char="." align="char">0.771</td><td char="." align="char">0.379</td><td char="." align="char">0.858</td></tr><tr><td align="left">Model 4</td><td align="left">0.452</td><td char="." align="char">0.856</td><td char="." align="char">0.746</td><td char="." align="char">0.759</td><td char="." align="char">0.308</td><td char="." align="char">0.832</td></tr><tr><td align="left">Model 5</td><td align="left">0.493</td><td char="." align="char">0.855</td><td char="." align="char">0.763</td><td char="." align="char">0.789</td><td char="." align="char">0.359</td><td char="." align="char">0.833</td></tr><tr><td align="left">Consensus model</td><td align="left"><bold>0.493</bold></td><td char="." align="char"><bold>0.925</bold></td><td char="." align="char"><bold>0.815</bold></td><td char="." align="char"><bold>0.801</bold></td><td char="." align="char"><bold>0.473</bold></td><td char="." align="char"><bold>0.882</bold></td></tr><tr><td align="left" rowspan="6"><p>Test set 2</p><p>(133)</p></td><td align="left">Model 1</td><td align="left">0.8</td><td char="." align="char">0.891</td><td char="." align="char">0.887</td><td char="." align="char">0.973</td><td char="." align="char">0.384</td><td char="." align="char">0.938</td></tr><tr><td align="left">Model 2</td><td align="left">1</td><td char="." align="char">0.859</td><td char="." align="char">0.865</td><td char="." align="char">0.978</td><td char="." align="char">0.432</td><td char="." align="char">0.924</td></tr><tr><td align="left">Model 3</td><td align="left">0.8</td><td char="." align="char">0.883</td><td char="." align="char">0.880</td><td char="." align="char">0.939</td><td char="." align="char">0.371</td><td char="." align="char">0.933</td></tr><tr><td align="left">Model 4</td><td align="left">1</td><td char="." align="char"><bold>0.914</bold></td><td char="." align="char">0.917</td><td char="." align="char">0.955</td><td char="." align="char">0.534</td><td char="." align="char"><bold>0.955</bold></td></tr><tr><td align="left">Model 5</td><td align="left">1</td><td char="." align="char">0.898</td><td char="." align="char">0.902</td><td char="." align="char">0.973</td><td char="." align="char">0.499</td><td char="." align="char">0.946</td></tr><tr><td align="left">Consensus model</td><td align="left">1</td><td char="." align="char">0.906</td><td char="." align="char"><bold>0.910</bold></td><td char="." align="char"><bold>0.981</bold></td><td char="." align="char"><bold>0.516</bold></td><td char="." align="char">0.951</td></tr></tbody></table><table-wrap-foot><p>Bold numbers refer to the maximum value (optimum value) obtained from the corresponding evaluation index</p></table-wrap-foot></table-wrap></p>
      <p id="Par37">The performance of our model is compared with that of ADMETlab [<xref ref-type="bibr" rid="CR16">16</xref>] on the two test sets (Table <xref rid="Tab8" ref-type="table">8</xref>). Our model showed lower ACC and AUC on test set 1 but better performance on test set 2. Because test set 1 comes from an earlier data set that was published before ADMETlab [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR28">28</xref>â<xref ref-type="bibr" rid="CR30">30</xref>], and has overlapping molecules with the training sets of several previous methods, it is likely that some molecules in test set 1 may be included in the training of ADMETlab (We were not able to obtain the training set of ADMETlab for removing of redundancy). On the other hand, the HOB data in test set 2 does not overlap with any published training sets and may server as a more objective testing of the two models.<table-wrap id="Tab8"><label>Table 8</label><caption><p>Comparison with ADMETlab on test sets 1 and 2 when the cutoff is 20%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Data set</th><th align="left">Model</th><th align="left">SE</th><th align="left">SP</th><th align="left">ACC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="2">Test set 1</td><td align="left">Current study</td><td align="left">0.493</td><td char="." align="char"><bold>0.925</bold></td><td char="." align="char">0.815</td><td char="." align="char">0.801</td></tr><tr><td align="left">ADMETlab</td><td align="left"><bold>0.904</bold></td><td char="." align="char">0.855</td><td char="." align="char"><bold>0.868</bold></td><td char="." align="char"><bold>0.947</bold></td></tr><tr><td align="left" rowspan="2">Test set 2</td><td align="left">Current study</td><td align="left"><bold>1</bold></td><td char="." align="char"><bold>0.906</bold></td><td char="." align="char"><bold>0.910</bold></td><td char="." align="char"><bold>0.981</bold></td></tr><tr><td align="left">ADMETlab</td><td align="left">0.8</td><td char="." align="char">0.844</td><td char="." align="char">0.842</td><td char="." align="char">0.902</td></tr></tbody></table><table-wrap-foot><p>Bold numbers refer to the maximum value (optimum value) obtained from the corresponding evaluation index</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec9">
      <title>Diversity distribution of HOB data</title>
      <p id="Par38">In this study, 1157, 290 and 141 molecules that have human oral availability data were collected for model construction. To examine the diversity of these molecules and provide a possible way to access the applicability of our model, we carried out principal component analysis (PCA) of these molecules. The 1143 fingerprints and descriptors mentioned above for model training were used to generate PCA for all compounds. We selected the two most important components to create a chemical space for characterizing training set, test set 1, and test set 2 (Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>). The results suggest that the chemical space of the two test sets is roughly within the space of the training set, therefore it is sensible to use the prediction model trained by the training set to predict the HOB values for the test sets. In addition, after removing an outlier in test set 1 (circled points in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>) that are outside the PCA space of the training set, the accuracy remains unchanged on test set 2 with 50% and 20% cutoff. Moreover, the PCA analysis can be used to determine the applicability of our model to new molecules. When the projection of a new molecule is within the range of the training molecules, it is considered as âinsideâ the application domain, indicating a more reliable prediction.<fig id="Fig3"><label>Fig. 3</label><caption><p>The chemical space of the training set (blue), the test set 1 (orange) and test set 2(green) using PCA factorization</p></caption><graphic xlink:href="13321_2021_580_Fig3_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Diversity evaluation of base learners</title>
      <p id="Par39">Diversity is very important in combining base learners. The Q-value approach is one way to measure the diversity of two classifiers [<xref ref-type="bibr" rid="CR31">31</xref>]. It ranges between ââ1 and 1, and is 0 if two classifiers are independent. The larger the Q value, the smaller the difference between the predictions of two classifiers. We used Q-value to measure the difference between the decision trees in each model. The average Q-value for individual trees in the five random forest models when the cutoff is 50% was 0.207, 0.233, 0.27, 0.241, and 0.267. When the cutoff is 20%, the Q-values were 0.235, 0.269, 0.288, 0.293, and 0.275, which suggest that these trees have high diversity.</p>
    </sec>
    <sec id="Sec11">
      <title>Importance of the input features</title>
      <p id="Par40">The analysis of important descriptors and fingerprints for prediction provides more information to fully understand these models. To this end, we used the SHapley Additive exPlanation (SHAP) algorithm to calculate the importance score of the input descriptor and fingerprints [<xref ref-type="bibr" rid="CR14">14</xref>]. SHAP (SHapley Additive exPlanations) is a game theory method used to explain the output of a machine learning model. It uses the classical Shapley value from game theory and its related extension to link the optimal credit allocation with local explanation.</p>
      <p id="Par41">We used the same method to analyze the contribution of each descriptor in the RF models when the cutoff is 50%, and the top 20 most important variables that contributed to the model were obtained through importance matrix plots (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S1âS5). The importance matrix plot for the consensus method was calculated by averaging the value in each model (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>A), which depicts the importance of each input feature in the development of the final predictive model. SsOH (number of all atoms) which is an atom type e-state descriptor contributes the most to predictive power, followed by the topological structure descriptor ATS5i and polar surface area descriptor TopoPSA (NO). In addition, we also counted the number of appearances of the features in the five individual models (Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>B). SsOH, ATS4p and TopoPSA(NO) appear three times among the 20 most important descriptors of the five models. In the two methods of quantifying feature importance, the specific information of the top 20 features is sorted in Table <xref rid="Tab9" ref-type="table">9</xref>.<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>A</bold> Importance matrix plot of the consensus model when the cutoff is 50%. <bold>B</bold> A statistical graph of the number of occurrences of the top 20 features that affect all models when the cutoff is 50%</p></caption><graphic xlink:href="13321_2021_580_Fig4_HTML" id="MO5"/></fig><table-wrap id="Tab9"><label>Table 9</label><caption><p>Description of the important features in the consensus model when the cutoff is 50%</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Descriptor category</th><th align="left">Feature name</th><th align="left">|shap value|</th><th align="left">Description</th></tr></thead><tbody><tr><td align="left">Estate</td><td align="left">SsOH</td><td char="." align="char">0.0239</td><td align="left">Sum of sOH</td></tr><tr><td align="left">TopoPSA</td><td align="left">TopoPSA(NO)</td><td char="." align="char">0.0178</td><td align="left">Topological polar surface area (use only nitrogen and oxygen)</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATSC0c</td><td char="." align="char">0.0172</td><td align="left">Centered MoreauâBroto autocorrelation of lag 0 weighted by Gasteiger charge</td></tr><tr><td align="left">Autocorrelation</td><td align="left">GATS1Z</td><td char="." align="char">0.0169</td><td align="left">MoreauâBroto autocorrelation of lag 1 weighted by atomic number</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATS5pe</td><td char="." align="char">0.0167</td><td align="left">MoreauâBroto autocorrelation of lag 5 weighted by Pauling EN</td></tr><tr><td align="left">TopoPSA</td><td align="left">TopoPSA</td><td char="." align="char">0.0161</td><td align="left">Topological polar surface area</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATS5se</td><td char="." align="char">0.0160</td><td align="left">MoreauâBroto autocorrelation of lag 5 weighted by Sanderson EN</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATS4p</td><td char="." align="char">0.0150</td><td align="left">MoreauâBroto autocorrelation of lag 4 weighted by polarizability</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATS4i</td><td char="." align="char">0.0144</td><td align="left">MoreauâBroto autocorrelation of lag 4 weighted by ionization potential</td></tr><tr><td align="left">Autocorrelation</td><td align="left">GATS1are</td><td char="." align="char">0.0131</td><td align="left">Geary coefficient of lag 1 weighted by AllredâRocow EN</td></tr><tr><td align="left">Autocorrelation</td><td align="left">GATS1pe</td><td char="." align="char">0.0126</td><td align="left">Geary coefficient of lag 1 weighted by Pauling EN</td></tr><tr><td align="left">MoeType</td><td align="left">VSA_EState3</td><td char="." align="char">0.0122</td><td align="left">VSA EState Descriptor 3 (5.00ââ¤â<italic>x</italic>â&lt;â5.41)</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATS5are</td><td char="." align="char">0.0122</td><td align="left">MoreauâBroto autocorrelation of lag 5 weighted by AllredâRocow EN</td></tr><tr><td align="left">Autocorrelation</td><td align="left">GATS1m</td><td char="." align="char">0.0122</td><td align="left">Geary coefficient of lag 1 weighted by mass</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATSC1are</td><td char="." align="char">0.0115</td><td align="left">Centered MoreauâBroto autocorrelation of lag 1 weighted by AllredâRocow EN</td></tr><tr><td align="left">Autocorrelation</td><td align="left">ATSC1c</td><td char="." align="char">0.0112</td><td align="left">Centered MoreauâBroto autocorrelation of lag 1 weighted by Gasteiger charge</td></tr><tr><td align="left">InformationContent</td><td align="left">BIC0</td><td char="." align="char">0.0111</td><td align="left">0-ordered bonding information content</td></tr><tr><td align="left">Autocorrelation</td><td align="left">GATS2Z</td><td char="." align="char">0.0110</td><td align="left">Geary coefficient of lag 2 weighted by atomic number</td></tr><tr><td align="left">AtomCount</td><td align="left">nAtom</td><td char="." align="char">0.0109</td><td align="left">Molecular ID on O atoms</td></tr></tbody></table></table-wrap></p>
      <p id="Par42">The SHAP dependence plot is further used to understand how a single feature affects the output of the prediction models, where the color bar indicates the actual values of the features, and the SHAP values are plotted on the <italic>x</italic>-axis. The dependence plot of the consensus model when the cutoff is 50% was obtained by averaging the contributions of the individual models (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S6â10). For each feature, a dot is created for each molecule, and positive SHAP values for a specific feature represent an increase in the predicted HOB value. For example, TopoPSA (NO) (topological polar surface area, using only nitrogen and oxygen) is an important feature that is overall negatively correlated with HOB (Fig.Â <xref rid="Fig5" ref-type="fig">5</xref>), i.e., a higher TopoPSA(NO) value will reduce the predicted HOB value. This is consistent with the finding that reducing the polar surface area increases the permeation rate of a molecule [<xref ref-type="bibr" rid="CR32">32</xref>]. Similarly, the TopoPSA descriptor which calculates the entire polar surface area is also negatively correlated with the HOB value.<fig id="Fig5"><label>Fig. 5</label><caption><p>SHAP dependence plot of the top 20 features of the consensus model when the cutoff is 50%</p></caption><graphic xlink:href="13321_2021_580_Fig5_HTML" id="MO6"/></fig></p>
      <p id="Par43">In addition, SsOH which is the total number of OH bonds also significantly affects the prediction of HOB. The blue dots are mainly concentrated in the area where the SHAP is greater than 0, therefore a small SsOH value will increase the HOB value. Decreasing the number of OH groups will increase the hydrophobicity and membrane absorption of a molecule, therefore leading to higher HOB. This is in line with the Lipinski's âRule-of-Fiveâ [<xref ref-type="bibr" rid="CR33">33</xref>]: if the number of hydrogen bond donors exceeds 5, the absorption or permeability may be poor [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
      <p id="Par44">It is believed that the charge state of molecules exerts a key influence on the perception of biomolecules (including membranes, enzymes and transporters) [<xref ref-type="bibr" rid="CR35">35</xref>]. Several features that have great influence in the consensus model, such as RPCG in RF1, ATSC0c in RF2 and RNCG in RF4 are charge related descriptors.</p>
      <p id="Par45">Using the same method, we also analyzed the model obtained with the 20% cutoff, and obtained importance matrix plots (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S11âS15, S21) and the dependence plots (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S16âS20, S22) of the individual and the consensus models. The important features from the models trained with the two cutoffs are overall consistent, e.g., <italic>TopoPSA (NO)</italic>, <italic>SsOH</italic> and <italic>Autocorrelation</italic> also have a significant impact on the Fâ=â20% consensus model as that on the Fâ=â50% model.</p>
    </sec>
  </sec>
  <sec id="Sec12">
    <title>Discussion and conclusions</title>
    <p id="Par46">On the basis of a comprehensive data sets collected in this study, accurate RF models for prediction of HOB were developed. Moreover, we also analyzed the importance of the features, and found that the number of OH bonds and polar surface area of a molecule are negatively correlated with the HOB value, which is consistent with molecular characteristics that affect the oral drug bioavailability. The model is available as a web server at <ext-link ext-link-type="uri" xlink:href="http://www.icdrug.com/ICDrug/ADMET">www.icdrug.com/ICDrug/ADMET</ext-link>, which provides researchers with an accurate tool to quickly and automatically predict the HOB of new molecules without any machine learning or statistical modeling knowledge.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec13">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13321_2021_580_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1: Table S1.</bold> Cut-off values used in different studies and the number of positive and negative samples in each study. <bold>Table S2.</bold> List of descriptors calculated using Mordred. <bold>Table S3.</bold> The performance of the consensus model on the training set and each fold in the fivefold cross validation when the cutoff is 50%. <bold>Table S4.</bold> The performance of the consensus model on the training set and each fold in fivefold cross validation when the cutoff is 20%. <bold>Figure S1.</bold> The importance matrix plot for the RF model 1 when the cutoff is 50%. <bold>Figure S2.</bold> The importance matrix plot for the RF model 2 when the cutoff is 50%. <bold>Figure S3.</bold> The importance matrix plot for the RF model 3 when the cutoff is 50%. <bold>Figure S4.</bold> The importance matrix plot for the RF model 4 when the cutoff is 50%. <bold>Figure S5.</bold> The importance matrix plot for the RF model 5 when the cutoff is 50%. <bold>Figure S6.</bold> SHAP dependence plot of the top 20 features of the RF model 1 when the cutoff is 50%. <bold>Figure S7.</bold> SHAP dependence plot of the top 20 features of the RF model 2 when the cutoff is 50%. <bold>Figure S8.</bold> SHAP dependence plot of the top 20 features of the RF model 3 when the cutoff is 50%. <bold>Figure S9.</bold> SHAP dependence plot of the top 20 features of the RF model 4 when the cutoff is 50%. <bold>Figure S10.</bold> SHAP dependence plot of the top 20 features of the RF model 5 when the cutoff is 50%. <bold>Figure S11.</bold> The importance matrix plot for the RF model 1 when the cutoff is 20%. <bold>Figure S12.</bold> The importance matrix plot for the RF model 2 when the cutoff is 20%. <bold>Figure S13.</bold> The importance matrix plot for the RF model 3 when the cutoff is 20%. <bold>Figure S14.</bold> The importance matrix plot for the RF model 4 when the cutoff is 20%. <bold>Figure S15.</bold> The importance matrix plot for the RF model 5 when the cutoff is 20%. <bold>Figure S16.</bold> SHAP dependence plot of the top 20 features of the RF model 1 when the cutoff is 20%. <bold>Figure S17.</bold> SHAP dependence plot of the top 20 features of the RF model 2 when the cutoff is 20%. <bold>Figure S18.</bold> SHAP dependence plot of the top 20 features of the RF model 3 when the cutoff is 20%. <bold>Figure S19.</bold> SHAP dependence plot of the top 20 features of the RF model 4 when the cutoff is 20%. <bold>Figure S20.</bold> SHAP dependence plot of the top 20 features of the RF model 5 when the cutoff is 20%. <bold>Figure S21.</bold> (A) Importance matrix plot of the consensus model when the cutoff is 20%. (B) A statistical graph of the number of occurrences of the top 20 features that affect all models when the cutoff is 20%. <bold>Figure S22.</bold> SHAP dependence plot of the top 20 features of the consensus model when the cutoff is 20%.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>HOB</term>
        <def>
          <p id="Par3">Human oral bioavailability</p>
        </def>
      </def-item>
      <def-item>
        <term>ADMET</term>
        <def>
          <p id="Par4">Absorption, distribution, metabolism, excretion, and toxicity</p>
        </def>
      </def-item>
      <def-item>
        <term>QSPR</term>
        <def>
          <p id="Par5">Quantitative structure property relationships</p>
        </def>
      </def-item>
      <def-item>
        <term>SHAP</term>
        <def>
          <p id="Par6">The SHapley Additive exPlanation</p>
        </def>
      </def-item>
      <def-item>
        <term>SE</term>
        <def>
          <p id="Par7">Sensitivity</p>
        </def>
      </def-item>
      <def-item>
        <term>SP</term>
        <def>
          <p id="Par8">Specificity</p>
        </def>
      </def-item>
      <def-item>
        <term>ACC</term>
        <def>
          <p id="Par9">Accuracy of prediction</p>
        </def>
      </def-item>
      <def-item>
        <term>MCC</term>
        <def>
          <p id="Par10">Matthewâs correlation coefficient</p>
        </def>
      </def-item>
      <def-item>
        <term>ROC</term>
        <def>
          <p id="Par11">The receiver operating characteristic</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par12">The receiver operating characteristic curve and the area under the curve</p>
        </def>
      </def-item>
      <def-item>
        <term>RF</term>
        <def>
          <p id="Par13">Random forest</p>
        </def>
      </def-item>
      <def-item>
        <term>CART</term>
        <def>
          <p id="Par14">Classification and regression trees</p>
        </def>
      </def-item>
      <def-item>
        <term>MLP</term>
        <def>
          <p id="Par15">Multilayer perceptron</p>
        </def>
      </def-item>
      <def-item>
        <term>NB</term>
        <def>
          <p id="Par16">Naive Bayes</p>
        </def>
      </def-item>
      <def-item>
        <term>GBT</term>
        <def>
          <p id="Par17">Gradient boosted trees</p>
        </def>
      </def-item>
      <def-item>
        <term>SVM</term>
        <def>
          <p id="Par18">Support vector machines</p>
        </def>
      </def-item>
      <def-item>
        <term>PCA</term>
        <def>
          <p id="Par19">Principal component analysis</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The computer time was provided by the ECNU Multifunctional Platform for Innovation001.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors' contributions</title>
    <p>YQ and JZ designed the research plan. MW, XZ, XP, and BW performed the computational analysis. MW and YQ wrote the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by the National Key R&amp;D Program of China (Grant No. 2016YFA0501700), the National Natural Science Foundation of China (22033001, 21933010), and the Natural Science Foundation of Shanghai (19ZR1473600).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The training and test data sets and the trained models are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/whymin/HOB">https://github.com/whymin/HOB</ext-link> and the web server at <ext-link ext-link-type="uri" xlink:href="http://www.icdrug.com/ICDrug/ADMET">www.icdrug.com/ICDrug/ADMET</ext-link>. Other data are available from the corresponding author on reasonable request.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par47">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Waring</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Arrowsmith</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leach</surname>
            <given-names>AR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An analysis of the attrition of drug candidates from four major pharmaceutical companies</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2015</year>
        <volume>14</volume>
        <issue>7</issue>
        <fpage>475</fpage>
        <lpage>486</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd4609</pub-id>
        <pub-id pub-id-type="pmid">26091267</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van de Waterbeemd</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>ADMET in silico modelling: towards prediction paradise?</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2003</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>192</fpage>
        <lpage>204</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd1032</pub-id>
        <pub-id pub-id-type="pmid">12612645</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morishita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Peppas</surname>
            <given-names>NA</given-names>
          </name>
        </person-group>
        <article-title>Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization. Preface</article-title>
        <source>Adv Drug Deliv Rev</source>
        <year>2012</year>
        <volume>64</volume>
        <issue>6</issue>
        <fpage>479</fpage>
        <pub-id pub-id-type="doi">10.1016/j.addr.2012.02.008</pub-id>
        <pub-id pub-id-type="pmid">22388003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kennedy</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Managing the drug discovery/development interface</article-title>
        <source>Drug Discov Today</source>
        <year>1997</year>
        <volume>2</volume>
        <issue>10</issue>
        <fpage>436</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.1016/S1359-6446(97)01099-4</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ahmed</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Ramakrishnan</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>7</issue>
        <fpage>e40654</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0040654</pub-id>
        <pub-id pub-id-type="pmid">22815781</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Recent developments of in silico predictions of oral bioavailability</article-title>
        <source>Comb Chem High Throughput Screen</source>
        <year>2011</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>362</fpage>
        <lpage>374</lpage>
        <pub-id pub-id-type="doi">10.2174/138620711795508368</pub-id>
        <pub-id pub-id-type="pmid">21470180</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiong</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkab255</pub-id>
        <?supplied-pmid 34893908?>
        <pub-id pub-id-type="pmid">34893908</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Falcon-Cano</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Molina</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cabrera-Perez</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>ADME prediction with KNIME: development and validation of a publicly available workflow for the prediction of human oral bioavailability</article-title>
        <source>J Chem Inf Model</source>
        <year>2020</year>
        <volume>60</volume>
        <issue>6</issue>
        <fpage>2660</fpage>
        <lpage>2667</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.0c00019</pub-id>
        <pub-id pub-id-type="pmid">32379452</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties</article-title>
        <source>Bioinformatics</source>
        <year>2019</year>
        <volume>35</volume>
        <issue>6</issue>
        <fpage>1067</fpage>
        <lpage>1069</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty707</pub-id>
        <pub-id pub-id-type="pmid">30165565</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Sedykh</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chakravarti</surname>
            <given-names>SK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches</article-title>
        <source>Pharm Res</source>
        <year>2014</year>
        <volume>31</volume>
        <issue>4</issue>
        <fpage>1002</fpage>
        <lpage>1014</lpage>
        <pub-id pub-id-type="doi">10.1007/s11095-013-1222-1</pub-id>
        <pub-id pub-id-type="pmid">24306326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Svetnik</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liaw</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Random forest: a classification and regression tool for compound classification and QSAR modeling</article-title>
        <source>J Chem Inf Comput Sci</source>
        <year>2003</year>
        <volume>43</volume>
        <issue>6</issue>
        <fpage>1947</fpage>
        <lpage>1958</lpage>
        <pub-id pub-id-type="doi">10.1021/ci034160g</pub-id>
        <pub-id pub-id-type="pmid">14632445</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheridan</surname>
            <given-names>RP</given-names>
          </name>
        </person-group>
        <article-title>Using random forest to model the domain applicability of another random forest model</article-title>
        <source>J Chem Inf Model</source>
        <year>2013</year>
        <volume>53</volume>
        <issue>11</issue>
        <fpage>2837</fpage>
        <lpage>2850</lpage>
        <pub-id pub-id-type="doi">10.1021/ci400482e</pub-id>
        <pub-id pub-id-type="pmid">24152204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Breiman</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Random forests</article-title>
        <source>Mach Learn</source>
        <year>2001</year>
        <volume>45</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1023/A:1010933404324</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Lundberg SM, Lee SI (2017) A unified approach to interpreting model predictions. In: Advances in neural information processing systems, pp 4765â4774</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method</article-title>
        <source>J Pharm Biomed Anal</source>
        <year>2008</year>
        <volume>47</volume>
        <issue>4â5</issue>
        <fpage>677</fpage>
        <lpage>682</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jpba.2008.03.023</pub-id>
        <pub-id pub-id-type="pmid">18455346</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>NN</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>ZJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database</article-title>
        <source>J Cheminform</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>29</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-018-0283-x</pub-id>
        <pub-id pub-id-type="pmid">29943074</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Olivares-Morales</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hatley</surname>
            <given-names>OJ</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data</article-title>
        <source>Pharm Res</source>
        <year>2014</year>
        <volume>31</volume>
        <issue>3</issue>
        <fpage>720</fpage>
        <lpage>730</lpage>
        <pub-id pub-id-type="doi">10.1007/s11095-013-1193-2</pub-id>
        <pub-id pub-id-type="pmid">24072264</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>El-Rashidy</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Estimation of the systemic bioavailability of timolol in man</article-title>
        <source>Biopharm Drug Dispos</source>
        <year>1981</year>
        <volume>2</volume>
        <issue>2</issue>
        <fpage>197</fpage>
        <lpage>202</lpage>
        <pub-id pub-id-type="doi">10.1002/bdd.2510020213</pub-id>
        <pub-id pub-id-type="pmid">7248483</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Korte</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Kaila</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Saari</surname>
            <given-names>KM</given-names>
          </name>
        </person-group>
        <article-title>Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops</article-title>
        <source>Graefes Arch Clin Exp Ophthalmol</source>
        <year>2002</year>
        <volume>240</volume>
        <issue>6</issue>
        <fpage>430</fpage>
        <lpage>5</lpage>
        <pub-id pub-id-type="doi">10.1007/s00417-002-0462-2</pub-id>
        <pub-id pub-id-type="pmid">12107508</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Johansson</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Knutsson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Leonsson-Zachrisson</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Effect of food intake on the pharmacodynamics of tenapanor: a phase 1 study</article-title>
        <source>Clin Pharmacol Drug Dev</source>
        <year>2017</year>
        <volume>6</volume>
        <issue>5</issue>
        <fpage>457</fpage>
        <lpage>465</lpage>
        <pub-id pub-id-type="doi">10.1002/cpdd.341</pub-id>
        <pub-id pub-id-type="pmid">28339149</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">FDA Approved Drug Products: Lysteda (tranexamic acid) tablets for oral use. <ext-link ext-link-type="uri" xlink:href="https://link.springer.com/content/pdf/10.1007%2F3-540-44938-8_31.pdf">https://link.springer.com/content/pdf/10.1007%2F3-540-44938-8_31.pdf</ext-link></mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moriwaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Kawashita</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mordred: a molecular descriptor calculator</article-title>
        <source>J Cheminform</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>4</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-018-0258-y</pub-id>
        <pub-id pub-id-type="pmid">29411163</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>KP</given-names>
          </name>
          <name>
            <surname>Basant</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Support vector machines in water quality management</article-title>
        <source>Anal Chim Acta</source>
        <year>2011</year>
        <volume>703</volume>
        <issue>2</issue>
        <fpage>152</fpage>
        <lpage>162</lpage>
        <pub-id pub-id-type="doi">10.1016/j.aca.2011.07.027</pub-id>
        <pub-id pub-id-type="pmid">21889629</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Strumbelj</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kononenko</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>An efficient explanation of individual classifications using game theory</article-title>
        <source>J Mach Learn Res</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>1532â4435</issue>
        <fpage>1</fpage>
        <lpage>18</lpage>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lei</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling</article-title>
        <source>J Cheminform</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>6</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-016-0117-7</pub-id>
        <pub-id pub-id-type="pmid">26839598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Quantitative structure-activity relationship modeling of rat acute toxicity by oral exposure</article-title>
        <source>Chem Res Toxicol</source>
        <year>2009</year>
        <volume>22</volume>
        <issue>12</issue>
        <fpage>1913</fpage>
        <lpage>1921</lpage>
        <pub-id pub-id-type="doi">10.1021/tx900189p</pub-id>
        <pub-id pub-id-type="pmid">19845371</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>A novel strategy of structural similarity based consensus modeling</article-title>
        <source>Mol Inform</source>
        <year>2013</year>
        <volume>32</volume>
        <issue>7</issue>
        <fpage>599</fpage>
        <lpage>608</lpage>
        <pub-id pub-id-type="doi">10.1002/minf.201200170</pub-id>
        <pub-id pub-id-type="pmid">27481768</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints</article-title>
        <source>Mol Pharm</source>
        <year>2011</year>
        <volume>8</volume>
        <issue>3</issue>
        <fpage>841</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1021/mp100444g</pub-id>
        <pub-id pub-id-type="pmid">21548635</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Varma</surname>
            <given-names>MVS</given-names>
          </name>
          <name>
            <surname>Obach</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Rotter</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination</article-title>
        <source>J Med Chem</source>
        <year>2010</year>
        <volume>53</volume>
        <issue>3</issue>
        <fpage>1098</fpage>
        <lpage>1108</lpage>
        <pub-id pub-id-type="doi">10.1021/jm901371v</pub-id>
        <pub-id pub-id-type="pmid">20070106</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>DÃ¶rwald</surname>
            <given-names>FZ</given-names>
          </name>
        </person-group>
        <source>Lead optimization for medicinal chemists: pharmacokinetic properties of functional groups and organic compounds</source>
        <year>2012</year>
        <publisher-loc>Weinheim, Germany</publisher-loc>
        <publisher-name>Wiley-VCH</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuncheva</surname>
            <given-names>LI</given-names>
          </name>
          <name>
            <surname>Whitaker</surname>
            <given-names>CJ</given-names>
          </name>
        </person-group>
        <article-title>Measures of diversity in classifier ensembles and their relationship with the ensemble accuracy</article-title>
        <source>Mach Learn</source>
        <year>2003</year>
        <volume>51</volume>
        <issue>2</issue>
        <fpage>181</fpage>
        <lpage>207</lpage>
        <pub-id pub-id-type="doi">10.1023/A:1022859003006</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Veber</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>HY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Molecular properties that influence the oral bioavailability of drug candidates</article-title>
        <source>J Med Chem</source>
        <year>2002</year>
        <volume>45</volume>
        <issue>12</issue>
        <fpage>2615</fpage>
        <lpage>2623</lpage>
        <pub-id pub-id-type="doi">10.1021/jm020017n</pub-id>
        <pub-id pub-id-type="pmid">12036371</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lipinski</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Lombardo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dominy</surname>
            <given-names>BW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title>
        <source>Adv Drug Deliv Rev</source>
        <year>1997</year>
        <volume>23</volume>
        <issue>1â3</issue>
        <fpage>3</fpage>
        <lpage>25</lpage>
        <pub-id pub-id-type="doi">10.1016/S0169-409X(96)00423-1</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?</article-title>
        <source>J Chem Inf Model</source>
        <year>2007</year>
        <volume>47</volume>
        <issue>2</issue>
        <fpage>460</fpage>
        <lpage>3</lpage>
        <pub-id pub-id-type="doi">10.1021/ci6003515</pub-id>
        <pub-id pub-id-type="pmid">17381169</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Martin</surname>
            <given-names>YC</given-names>
          </name>
        </person-group>
        <article-title>A bioavailability score</article-title>
        <source>J Med Chem</source>
        <year>2005</year>
        <volume>48</volume>
        <issue>9</issue>
        <fpage>3164</fpage>
        <lpage>3170</lpage>
        <pub-id pub-id-type="doi">10.1021/jm0492002</pub-id>
        <pub-id pub-id-type="pmid">15857122</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
